These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Efficacy of low-density lipoprotein apheresis in arteriosclerosis obliterans of the lower extremities: two cases with marked alleviation of clinical symptoms. Suzuki T; Sato Y; Niizuma S; Kushiro T; Tani S; Ishikawa K; Kajiwara N; Kanmatsuse K; Ikeda H; Takahashi M; Kojima S J Clin Apher; 2007; 22(5):287-91. PubMed ID: 17610290 [TBL] [Abstract][Full Text] [Related]
28. Effects of Valsartan on Restenosis in Patients with Arteriosclerosis Obliterans of the Lower Extremities Undergoing Interventional Therapy: A Prospective, Randomized, Single-Blind Trial. Yao W; Wang L; Chen Q; Wang F; Feng N Med Sci Monit; 2020 Jun; 26():e919977. PubMed ID: 32541643 [TBL] [Abstract][Full Text] [Related]
29. [Femoral-popliteal Arteriosclerosis Obliterans:Review of Evidence-based Studies on Drug-eluting Endovascular Treatment]. Zhang R; Lai ZC; Liu CW Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Apr; 41(2):256-260. PubMed ID: 31060683 [TBL] [Abstract][Full Text] [Related]
30. Efficacy of Endovascular Radiofrequency Ablation for Thromboangiitis Obliterans (Buerger's Disease). Tang J; Gan S; Zheng M; Jiang Y; Feng Y; Miao J Ann Vasc Surg; 2017 Jul; 42():78-83. PubMed ID: 28341508 [TBL] [Abstract][Full Text] [Related]
31. [Correction of dyslipidemia in patients with arteriosclerosis obliterans as a method for improving the results of endovascular angioplasty]. Petukhov VA; Seitmykhamedov MD; Dibirov AD; Dubovik SG; Sergeeva NA; Prokubovskiĭ VI Grud Serdechnososudistaia Khir; 1992; (7-8):33-5. PubMed ID: 1457133 [TBL] [Abstract][Full Text] [Related]
32. Effect of diabetes on the prognosis, serum inflammatory factors, and quality of life of patients with lower extremity arteriosclerosis obliterans after vascular intervention: a retrospective comparative cohort study. Zhao H; Zhuo T; Hao X; Fan X; Zhao P Ann Palliat Med; 2022 Aug; 11(8):2720-2729. PubMed ID: 36064362 [TBL] [Abstract][Full Text] [Related]
33. Clinical Significance of Endothelin-1 And C Reaction Protein in Restenosis After the Intervention of Lower Extremity Arteriosclerosis Obliterans. Lian W; Nie H; Yuan Y; Wang K; Chen W; Ding L J Invest Surg; 2021 Jul; 34(7):765-770. PubMed ID: 31996054 [TBL] [Abstract][Full Text] [Related]
34. [Use of gravity therapy and discrete plasmapheresis in treatment of atherosclerosis obliterans]. Lukashova AV; Makarov IV; Lopukhov ES Angiol Sosud Khir; 2014; 20(4):49-53. PubMed ID: 25490357 [TBL] [Abstract][Full Text] [Related]
35. [Partial denervation in complex treatment of occlusive diseases of the lower extremity arteries]. Sander SV Klin Khir; 2011 Mar; (3):45-8. PubMed ID: 21698817 [TBL] [Abstract][Full Text] [Related]
36. [Plasma heparin cofactor II activity correlates with the incidence of in-stent restenosis after the intervention of arteriosclerosis obliterans in lower extremity]. Lu H; Guo P Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Feb; 40(2):177-81. PubMed ID: 25769326 [TBL] [Abstract][Full Text] [Related]
37. [Organizational aspects of managing patients with atherosclerosis obliterans of lower-limb vessels at an ambulatory stage]. Lonchakova IY; Makarov SA; Artamonova GV; Barbarash LS Angiol Sosud Khir; 2015; 21(3):38-42. PubMed ID: 26355921 [TBL] [Abstract][Full Text] [Related]
38. [Doppler ultrasonic examination in assessing the outcome of the therapeutic method in patients with arteriosclerosis obliterans of the lower extremities]. Uza G; Dosan L; Vlaicu R Med Interna; 1991; 43(1-2):81-8. PubMed ID: 1670128 [TBL] [Abstract][Full Text] [Related]
39. Percutaneous transluminal angioplasty: a nonoperative treatment of occlusive vascular disease. Black TJ J Maine Med Assoc; 1979 Aug; 70(8):318-21. PubMed ID: 512501 [No Abstract] [Full Text] [Related]
40. [Treatment of lower extremity diabetic atherosclerotic obliterans with shuxuetong injection]. Feng K; Tan JF; Chen Y Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Mar; 29(3):255-7. PubMed ID: 19548446 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]